Nkarta, Inc. Basic Shares Outstanding (Weighted Average)
Nkarta, Inc. (NKTX) reported Basic Shares Outstanding (Weighted Average) of 74.49 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-10
- Nkarta, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 74.49M shares, a 0.70% increase year-over-year.
- Nkarta, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 74.26M shares, a 0.46% increase year-over-year.
- Nkarta, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 74.04M shares, a 0.55% increase year-over-year.
- Nkarta, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 74.02M shares, a 0.63% increase year-over-year.
- Nkarta, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 73.99M shares, a 9.03% increase from fiscal 2024.
- Nkarta, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 67.87M shares, a 38.46% increase from fiscal 2023.
- Nkarta, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 49.01M shares, a 12.34% increase from fiscal 2022.
- Nkarta, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 43.63M shares, a 32.79% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 74.49M shares 10-Q · filed 2026-08-10 | 74.38M shares 10-Q · filed 2026-08-10 | 74.27M shares derived: average of 3 quarters · filed 2026-08-10 | 74.21M shares derived: average of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | 74.26M shares 10-Q · filed 2026-05-12 | 74.15M shares derived: average of 2 quarters · filed 2026-05-12 | 74.11M shares derived: average of 3 quarters · filed 2026-05-12 | 74.08M shares derived: average of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | 74.04M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | 74.03M shares derived: average of 2 quarters · filed 2026-03-25 | 74.02M shares derived: average of 3 quarters · filed 2026-08-10 | 73.99M shares 10-K · filed 2026-03-25 |
| 2025-09-30 | 74.02M shares 10-Q · filed 2025-11-10 | 74.00M shares derived: average of 2 quarters · filed 2026-08-10 | 73.97M shares 10-Q · filed 2025-11-10 | 73.89M shares derived: average of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | 73.98M shares 10-Q · filed 2026-08-10 | 73.95M shares 10-Q · filed 2026-08-10 | 73.84M shares derived: average of 3 quarters · filed 2026-08-10 | 73.77M shares derived: average of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | 73.92M shares 10-Q · filed 2026-05-12 | 73.78M shares derived: average of 2 quarters · filed 2026-05-12 | 73.71M shares derived: average of 3 quarters · filed 2026-05-12 | 73.65M shares derived: average of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | 73.64M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | 73.60M shares derived: average of 2 quarters · filed 2026-03-25 | 73.57M shares derived: average of 3 quarters · filed 2026-03-25 | 67.87M shares 10-K · filed 2026-03-25 |
| 2024-09-30 | 73.56M shares 10-Q · filed 2025-11-10 | 73.53M shares derived: average of 2 quarters · filed 2025-11-10 | 65.94M shares 10-Q · filed 2025-11-10 | 61.71M shares derived: average of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | 73.49M shares 10-Q · filed 2025-08-12 | 62.09M shares 10-Q · filed 2025-08-12 | 57.76M shares derived: average of 3 quarters · filed 2025-08-12 | 55.59M shares derived: average of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | 50.68M shares 10-Q · filed 2025-05-14 | 49.89M shares derived: average of 2 quarters · filed 2025-05-14 | 49.62M shares derived: average of 3 quarters · filed 2025-05-14 | 49.45M shares derived: average of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | 49.10M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | 49.08M shares derived: average of 2 quarters · filed 2025-03-26 | 49.04M shares derived: average of 3 quarters · filed 2025-03-26 | 49.01M shares 10-K · filed 2025-03-26 |
| 2023-09-30 | 49.06M shares 10-Q · filed 2024-11-07 | 49.02M shares derived: average of 2 quarters · filed 2024-11-07 | 48.99M shares 10-Q · filed 2024-11-07 | 48.96M shares derived: average of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | 48.97M shares 10-Q · filed 2024-08-13 | 48.95M shares 10-Q · filed 2024-08-13 | 48.93M shares derived: average of 3 quarters · filed 2024-08-13 | 48.85M shares derived: average of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | 48.92M shares 10-Q · filed 2024-05-09 | 48.91M shares derived: average of 2 quarters · filed 2024-05-09 | 48.81M shares derived: average of 3 quarters · filed 2024-05-09 | 47.57M shares derived: average of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | 48.89M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | 48.76M shares derived: average of 2 quarters · filed 2024-03-21 | 47.12M shares derived: average of 3 quarters · filed 2024-03-21 | 43.63M shares 10-K · filed 2024-03-21 |
| 2022-09-30 | 48.63M shares 10-Q · filed 2023-11-09 | 46.24M shares derived: average of 2 quarters · filed 2023-11-09 | 41.88M shares 10-Q · filed 2023-11-09 | 39.61M shares derived: average of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | 43.84M shares 10-Q · filed 2023-08-10 | 38.45M shares 10-Q · filed 2023-08-10 | 36.60M shares derived: average of 3 quarters · filed 2023-08-10 | 35.67M shares derived: average of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | 32.99M shares 10-Q · filed 2023-05-11 | 32.97M shares derived: average of 2 quarters · filed 2023-05-11 | 32.95M shares derived: average of 3 quarters · filed 2023-05-11 | 32.92M shares derived: average of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | 32.96M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | 32.93M shares derived: average of 2 quarters · filed 2023-03-16 | 32.90M shares derived: average of 3 quarters · filed 2023-03-16 | 32.86M shares 10-K · filed 2023-03-16 |
| 2021-09-30 | 32.90M shares 10-Q · filed 2022-11-09 | 32.87M shares derived: average of 2 quarters · filed 2022-11-09 | 32.82M shares 10-Q · filed 2022-11-09 | |
| 2021-06-30 | 32.83M shares 10-Q · filed 2022-08-11 | 32.78M shares 10-Q · filed 2022-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |